Skip to main content
. 2019 Nov 14;13:495. doi: 10.3389/fncel.2019.00495

Table 1.

Drugs used in the study.

Drugs Mechanisms of action Solvent Source
SP600125 A selective inhibitor of c-Jun N-terminal kinase 1% DMSO Calbiochem
MK-801 A non-competitive NMDA receptor antagonist saline Sigma
Ifenprodil A selective antagonist of NMDA receptors containing the NR2B subunit 1% DMSO Sigma
NMDA A specific agonist of the NMDA receptor 1% DMSO Sigma
7-NINA A selective neuronal nitric oxide synthase inhibitor 20% DMSO Sigma
ODQ A selective inhibitor of the nitric oxide sensitive guanylyl cyclase 20% DMSO Sigma